EP1T31 Platelet PBM: beyond red blood cells, managing platelet transfusion in neurosurgical emergencies with point-of-care testing

This is the authors' abstract. We don't add key points for this paper.

Platelet transfusion is frequently administered empirically in emergency patients receiving antiplatelet therapy requiring urgent invasive procedures, particularly neurosurgeries. Platelet inhibition with acetylsalicylic acid (AAS) or P2Y12 inhibitors is highly variable, and indiscriminate platelet transfusion exposes patients to unnecessary risks and contributes to platelet wastage.